Innovex International, Inc. cash flow to debt ratio of 158.73% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Innovex International, Inc.'s free cash flow has increased 95.10% from $79.84M last year to $155.78M, signaling increasing performance

Innovex International, Inc.'s debt to equity ratio is 0.07, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Innovex International, Inc.'s debt has decreased relative to shareholder equity from 0.10 last year to 0.07 today, signaling strengthened financials

Innovex International, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Innovex International, Inc.'s interest coverage ratio of 70.86 indicates that earnings with good margin can cover interest payments on company debt

Innovex International, Inc.'s profit margin has decreased (-75.00%) in the last year from 21.24% to 5.31%, signaling decreasing performance

Innovex International, Inc.'s short-term assets of $728.05M exceed its short-term liabilities of $148.16M

Innovex International, Inc.'s return on assets of 4.03% is lower than the 5.00% threshold, indicating inefficient asset utilization

Innovex International, Inc.'s return on equity of 5.03%, is lower than 15.00%, indicating bad performance

Innovex International, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Innovex International, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

Innovex International, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Innovex International, Inc. has a free cash flow yield of 8.81%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Innovex International, Inc.'s yearly earnings has decreased -40.64% since last year from $140.32M to $83.30M, signaling decreasing performance

Innovex International, Inc.'s yearly revenue has increased 48.04% since last year from $660.80M to $978.25M, signaling increasing performance

ROIC 5.54% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Innovex International, Inc.'s 3-year revenue CAGR of 27.93% is positive, indicating growing revenue over the past 3 years

Innovex International, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance

Innovex International, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity

Innovex International, Inc. has insufficient data to evaluate this check.

Innovex International, Inc. has an earnings yield of 2.93%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Innovex International, Inc. is overvalued relative to its fair value price of 20.80 based on EBITDA multiple model

Innovex International, Inc. has an EV/EBITDA ratio of 8.78x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Innovex International, Inc. is undervalued relative to its fair value price of 31.73 based on Earnings Fair Value model

Innovex International, Inc. has no meaningful EPS growth rate; PEG ratio cannot be computed.

Innovex International, Inc. has a price-to-book ratio of 1.72x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Innovex International, Inc. has a price-to-sales ratio of 1.82x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue